Sanofi Genzyme Overview

  • Founded
  • 1981
Founded
  • Status
  • Private
  • Employees
  • 10,000
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $20.4B
Latest Deal Amount
  • Investors
  • 1

Sanofi Genzyme General Information

Description

Manufacturer of human health-care products. The company focuses on rare genetic disease disorders, renal diseases, orthopedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas. It operates as a biotechnology company worldwide.

Contact Information

Website
www.sanofigenzyme.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • 50 Binney Street
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi Genzyme Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Apr-2011 $20.4B 000.00 000.00 Completed Generating Revenue
1. IPO 05-Jun-1986 000.00 000.00 Completed Generating Revenue
To view Sanofi Genzyme’s complete valuation and funding history, request access »

Sanofi Genzyme Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of human health-care products. The company focuses on rare genetic disease disorders, renal diseases, ortho
Biotechnology
Cambridge, MA
10,000 As of 2021
000.00
00.00 0000-00-00
000000&0 000.00

000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
Cambridge, MA
0000 As of 0000
000.00
000 0000-00-00
0&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sanofi Genzyme Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Formerly VC-backed Cambridge, MA 0000 000.00 0&0
You’re viewing 1 of 1 competitors. Get the full list »

Sanofi Genzyme Patents

  • 4,278

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 159

    Granted

  • 31

    Pending

  • 000

    Expiring in next 12 mo

Sanofi Genzyme Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210380719-A1 Rabbit antibodies to human immunoglobulins g Pending 01-Jun-2020 00000000000
US-20210332115-A1 Humanized anti-complement factor bb antibodies and uses thereof Pending 20-Apr-2020 000000000
US-20210292391-A1 Modified binding polypeptides for optimized drug conjugation Pending 28-Feb-2020 000000000
US-20210244803-A1 Compositions and methods for treating pompe disease Pending 08-Feb-2020 000000000
US-20210251982-A1 Methods for treating neurological symptoms associated with lysosomal storage diseases Pending 03-Feb-2020 A61K31/4748
To view Sanofi Genzyme’s complete patent history, request access »

Sanofi Genzyme Executive Team (35)

Name Title Board Seat Contact Info
Paul Hudson Chief Executive Officer
Jean-Baptiste Chatillon Chief Financial Officer & Executive Vice President
Bill Sibold Executive Vice President & Head
Robin Kenselaar Head of Europe
Philippe Sauvage Head of Global Operations and Access
You’re viewing 5 of 35 executive team members. Get the full list »

Sanofi Genzyme Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanofi Genzyme Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Perseus (Bethesda) PE/Buyout 000 0000 000000 0
To view Sanofi Genzyme’s complete investors history, request access »

Sanofi Genzyme Investments & Acquisitions (40)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 30-Apr-2015 00000 0000 0000 Drug Discovery
00000000 07-Jan-2015 0000 00000 00.000 Electronic Equipment and Instruments
000000 000000 12-Jan-2012 00000 0000 000.00 Consulting Services (B2B)
0000 00000 00 10-Jan-2012 00000 0000 00000 Drug Discovery
Zealand Pharma 23-Dec-2009 Later Stage VC 00000 Pharmaceuticals
You’re viewing 5 of 40 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Sanofi Genzyme Subsidiaries (6)

Company Name Industry Location Founded
ZyStor Therapeutics Biotechnology Wauwatosa, WI 2004
000000000 Drug Discovery Amsterdam, Netherlands 0000
00000000000 Pharmaceuticals New York, NY 0000
000000 00000000 Biotechnology Bridgewater, NJ 0000
00000 Surgical Devices Lexington, MA 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Sanofi Genzyme Exits (13)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 30-Apr-2015 00000 00000 00 0000 Completed
  • 6 buyers
000000 000000000 12-Jan-2012 00000 00000 00 000.00 Completed
  • 8 buyers
0000 00000 000 10-Jan-2012 00000 00000 00 00000 Completed
  • 3 buyers
0000000 000000 23-Dec-2009 00000 00000 00 00000 Completed
  • 5 buyers
Great Wall Semiconductor 08-Jul-2009 Later Stage VC Completed
  • 5 buyers
You’re viewing 5 of 13 exits. Get the full list »